These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22479381)

  • 21. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
    J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Erice A; Brambilla D; Bremer J; Jackson JB; Kokka R; Yen-Lieberman B; Coombs RW
    J Clin Microbiol; 2000 Aug; 38(8):2837-45. PubMed ID: 10921936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).
    Elbeik T; Surtihadi J; Destree M; Gorlin J; Holodniy M; Jortani SA; Kuramoto K; Ng V; Valdes R; Valsamakis A; Terrault NA
    J Clin Microbiol; 2004 Feb; 42(2):563-9. PubMed ID: 14766817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Nolte FS; Boysza J; Thurmond C; Clark WS; Lennox JL
    J Clin Microbiol; 1998 Mar; 36(3):716-20. PubMed ID: 9508301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
    Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
    Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
    J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow.
    Elbeik T; Markowitz N; Nassos P; Kumar U; Beringer S; Haller B; Ng V
    J Clin Microbiol; 2004 Jul; 42(7):3120-7. PubMed ID: 15243070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay.
    Rouet F; Montcho C; Rouzioux C; Leroy V; Msellati P; Kottan JB; You B; Viho I; Dabis F;
    AIDS; 2001 Sep; 15(14):1849-56. PubMed ID: 11579248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
    Vermehren J; Kau A; Gärtner BC; Göbel R; Zeuzem S; Sarrazin C
    J Clin Microbiol; 2008 Dec; 46(12):3880-91. PubMed ID: 18799708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.
    Pawlotsky JM; Martinot-Peignoux M; Poveda JD; Bastie A; Le Breton V; Darthuy F; Rémiré J; Erlinger S; Dhumeaux D; Marcellin P
    J Virol Methods; 1999 May; 79(2):227-35. PubMed ID: 10381092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients.
    Yang JF; Lin YY; Huang JF; Liu SF; Chu PY; Hsieh MY; Lin ZY; Chen SC; Wang LY; Dai CY; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2009 Aug; 25(8):413-22. PubMed ID: 19605335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance characteristics of quantification assays for human immunodeficiency virus type 1 RNA.
    Schmitt Y
    J Clin Virol; 2001 Jan; 20(1-2):31-3. PubMed ID: 11163580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
    Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
    J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.
    Church D; Gregson D; Lloyd T; Klein M; Beckthold B; Laupland K; Gill MJ
    J Clin Microbiol; 2011 Jan; 49(1):118-24. PubMed ID: 21084515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.
    Martinot-Peignoux M; Khiri H; Leclere L; Maylin S; Marcellin P; Halfon P
    J Clin Virol; 2009 Nov; 46(3):216-21. PubMed ID: 19748822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.
    Swanson P; Soriano V; Devare SG; Hackett J
    J Clin Microbiol; 2001 Mar; 39(3):862-70. PubMed ID: 11230396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.
    de Mendoza C; Koppelman M; Montès B; Ferre V; Soriano V; Cuypers H; Segondy M; Oosterlaken T
    J Virol Methods; 2005 Jul; 127(1):54-9. PubMed ID: 15893566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology.
    Todd J; Pachl C; White R; Yeghiazarian T; Johnson P; Taylor B; Holodniy M; Kern D; Hamren S; Chernoff D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S35-44. PubMed ID: 7552511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multilaboratory comparison of hepatitis C virus viral load assays.
    Caliendo AM; Valsamakis A; Zhou Y; Yen-Lieberman B; Andersen J; Young S; Ferreira-Gonzalez A; Tsongalis GJ; Pyles R; Bremer JW; Lurain NS
    J Clin Microbiol; 2006 May; 44(5):1726-32. PubMed ID: 16672399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.